UPWK just delivered one of its ugliest weeks in memory. The stock fell 16% on the day after its Q1 2026 results and lost nearly 16% across the week to close at $8.82 — a fresh 12-month low. The tension going into next quarter is sharp: shorts are actually trimming positions even as the stock collapses, while a wave of analyst downgrades is rewriting the Street's conviction in real time.
The positioning picture is more nuanced than the price action suggests. Short interest is genuinely elevated — nearly 19% of free float as of May 7, up from around 17.5% in early April — but the direction reversed sharply on the day of the earnings drop. Shorts cut about 10% from their peak in just one week, with SI falling from roughly 21% to 18.7% of free float in five sessions. That pattern looks more like covering into the selloff than fresh conviction. Cost to borrow has remained flat throughout, hovering near 0.45% APR — barely registering as a financing cost — and borrow availability is still loose relative to the size of the short book. The ORTEX short score is running at 66.9, down from a peak around 71.5 in late April, which points to the same direction of travel: less short-side pressure now than a week ago, not more. Options are a different story. The put/call ratio ran above 2.1 in the days leading into the print — near its 52-week high of 2.18 — before retreating to 1.67 by Friday. Protective demand was heavy ahead of results and has only partially unwound since.
The analyst community moved fast and in one direction. UBS cut the stock from Buy to Neutral and chopped its target from $20 to $10. Canaccord made the same call, slashing from Buy to Hold and dropping its target from $22 to $10. Citizens downgraded to Market Perform and Scotiabank lowered its target to $10 while staying at Sector Perform — all on May 8, the day after earnings. Needham held its Buy but cut to $15 from $25, making it the lone remaining bull in a room that has largely emptied out. The consensus is now 2 Buys, 1 Outperform, and 8 Holds, with a mean price target of $14.56 — still 65% above Friday's close. That gap is notable, though it partly reflects the speed of the cuts; targets will likely continue to migrate lower. The stock trades at a PE of around 6.9x and an EV/EBITDA of 4.2x — cheap on any screen — but the bear case is exactly that cheapness on trailing metrics does not tell you when revenue headwinds from AI-driven platform disruption ease. The EV/EBIT factor score sits in the 88th percentile, confirming the valuation discount, while the short score rank (5th percentile) flags that bearish positioning remains a material feature of this name.
The institutional flow heading into the quarter added context. BlackRock added 8.5 million shares in April — a meaningful accumulation. T. Rowe added nearly 5.9 million shares through March-end. Both moves were made at prices well above current levels, which means these holders are sitting on significant paper losses after this week's move. Whether that creates support or becomes a source of selling pressure depends on how Q2 guidance shapes up.
Earnings history offers a clean datapoint. The most recent prior quarterly print, in February 2026, produced a 2.9% positive 1-day move. This week's release triggered a negative 12.5% reaction — a clear step change in investor disappointment. The next earnings event is scheduled for June 4, roughly four weeks out. That is a short runway. Options positioning between now and that date — whether the put/call ratio rebuilds or stays depressed — will indicate how quickly the market decides the Q1 miss was a one-off versus the start of a trend.
What to watch next: whether short interest continues to fall despite the price weakness, which would confirm a covering dynamic rather than fresh shorts piling in; and whether any of the downgrading firms revisit their targets a second time after the June 4 earnings call given that most new $10 targets were filed before the stock had fully priced in the results.
See the live data behind this article on ORTEX.
Open UPWK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
